Skip to content

Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.

Xenon Inhalation as Cover Sedation During Orthopaedic Surgery in Elderly Subjects Comparing the Effects of Inhaled Xenon and Intravenous Propofol

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00192959
Enrollment
44
Registered
2005-09-19
Start date
2004-03-31
Completion date
2004-12-31
Last updated
2005-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia, Postoperative Cognitive Function

Keywords

Anaesthesia, Surgery, Postoperative, Neuropsychological test

Brief summary

The primary objective was to explore the feasibility of inhaled xenon for sedation in terms of its effect on postoperative cognitive function in elderly, in comparison with the postoperative cognitive function found after IV propofol sedation in the same population.The secondary objectives were designed to assess the feasibility of xenon sedation in terms of its effects on different neuropsycho-logical test variables, vital signs, sedation levels and safety in elderly orthopaedic subjects.

Detailed description

Primary endpoint: - The primary efficacy parameter was a combined score based on the seven variables derived from four validated neuropsychological tests of cognitive function; Visual Verbal Learning test, Concept Shifting test, Stroop Color Word Interference test and Letter Digit Coding test. The parameter was used for comparing changes in test results between the screening and first postoperative follow-up testing for the treatment groups.Secondary endpoints:- Cognitive performance changes from baseline to the first post-operative follow-up judged separately for each of the seven variables from the changes in the test results.- Cognitive performance changes from baseline to the second postoperative follow-up judged separately and globally for each of the seven variables from the changes in test results.- Adequacy of ventilation (respiratory rate and pulse oximetry)- Adequacy of xenon sedation by monitoring depth of unconsciousness, signs of airway irritation, need for additional sedatives, time to recovery from anaesthesia. - Technical performance of xenon delivery device

Interventions

DRUGXenon vs propofol

Sponsors

Linde AG
CollaboratorINDUSTRY
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female subjects ≥ 60 years of age. * American Soc. of Anaesthesiologists Physical Status Classification (ASA) I-III status \[27\] * Referred for elective orthopaedic knee surgery with an anticipated duration of \> 45 min * Expected to remain in hospital for at least 3 days * Expected to be able to comply with the study protocol throughout the study period * Mini Mental State Examination (MMSE) score \> 23 * Informed consent given

Exclusion criteria

* Disease of the CNS (infectious, metabolic, tumours, dementia, epilepsy, major psychiatric disease, confusion/ delirium according to Diagnostic & Statistical Manual of Mental Disorders (DSM) IV criteria) * Contradiction for spinal anaesthesia * Contradiction for laryngeal mask * Regular use of tranquillisers, or antidepressants, if prescribed by psychiatrist for psychosis or depression * Undergone neuropsychological testing within the last year * Unable to follow study procedures, illiteracy, or poor comprehension of the language used in the psychometric tests * Severe visual or auditory disorder * Alcoholism or drug abuse CNS disease BMI \> 35 Inab

Design outcomes

Primary

MeasureTime frame
Primary endpoint: -cognitive function; Visual Verbal Learning test, Concept Shifting test, Stroop Color Word Interfer

Secondary

MeasureTime frame
Secondary endpoints:-
Vital signs
Side effects

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026